password
username
Sponsored by CakeMail, an email marketing software.
Newsletter preview

Philly.com
Inquirer Business Update
Video
Philadelphia Business Today 4/22
On "Philadelphia Business Today," an exclusive interview with Vanguard Group founder John Bogle, plus why Big Pharma has been hurting lately. »  View in larger player
Top Story
Posted 2:30pm
Southampton-based Environmental Tectonics Corp. announced today that the American Stock Exchange agreed to continue listing the company, at least through May 29.
BUSINESS BLOGS
You are what people say you are.

Merck & Co. Inc. does not like what some have been saying about its conduct regarding the drugs Vytorin and Zetia.

Those are the cholesterol fighters that were lambasted by several cardiologists at the American College of Cardiology meeting at the end of March. Results of a study by Merck and its partner, Schering-Plough, released in January showed little benefit compared against Merck’s simvastatin.

The backlash from that cardiology meeting moved Merck CEO Richard T. Clark to defend his company’s conduct on Monday's analysts call.

1 comment

»  More Blog Entries
Today's Inquirer
Merck & Co. Inc., which has lost patent protection on one of its big revenue producers, osteoporosis drug Fosamax, said yesterday that first-quarter sales rose 1 percent and earnings soared on a special $2.2 billion pretax gain from a limited partnership with AstraZeneca P.L.C.
NEW YORK - Rising gasoline prices tightened the squeeze on drivers yesterday, jumping to an average $3.50 a gallon at filling stations across the country.
MORE FROM TODAY'S INQUIRER
Reach out to us

Subscription information
Subscribe to our other newsletters, cancel your subscription or manage your account by visiting My Account.

If you no longer wish to receive this newsletter, you may also cancel your subscription by email.

Do you enjoy the contents of this newsletter and want to share the news?

Please do not reply to this email, as we are unable to respond to messages sent to this address. You can find answers to your questions through our online help.

Send us feedback. Written communications concerning this mailing may be directed to Philadelphia Inquirer, P.O. Box 8263, Business News - Reid Kanaley, Philadelphia, PA 19101.